Research Article

Evaluation of Lymphocyte-to-Monocyte Ratio and Mean Platelet Volume-to-Platelet Ratio in Rhegmatogenous Retinal Detachment

Table 1

Clinical features and laboratory parameters of included patients.

RRD groups (n = 83)Control group (n = 83) value

Age (years)51.8 ± 11.252.9 ± 10.60.493
Gender (male/female)45 (54.9%): 37 (45.1%)45 (54.9%): 37 (45.1%)1.00
High myopia (yes/no)20 (24.4%): 62 (75.6%)17 (20.7%): 65 (79.3%)0.575
White blood cell (× 109/L)5.86 ± 1.536.33 ± 1.750.138
Neutrophil (× 109/L)3.37 ± 1.253.64 ± 1.380.186
Lymphocyte (× 109/L)1.91 ± 0.532.00 ± 0.650.709
Monocyte (× 109/L)0.42 ± 0.120.49 ± 0.150.005
Platelet (× 109/L)212.68 ± 55.94232.90 ± 69.120.069
MPV (fL)11.12 ± 1.1510.70 ± 1.110.013
HDL-Ch (mmol/L)1.16 ± 0.251.17 ± 0.280.893
NLR0.56 ± 0.100.57 ± 0.090.805
PLR119.19 ± 45.13125.26 ± 48.430.254
LMR4.83 ± 1.524.27 ± 1.270.019
MPR0.06 ± 0.020.05 ± 0.020.037
MHR0.39 ± 0.160.45 ± 0.180.044

MPV, mean platelet volume; HDL-Ch, high-density lipoprotein cholesterol; NLR, neutrophil-to-lymphocyte ratio; PLR, platelet-to-lymphocyte ratio; LMR, lymphocyte-to-monocyte ratio; MPR, MPV-to-platelet ratio; MHR, monocyte-to-high-density lipoprotein. values in bold are significant.